HENAN SUNLAKE ENTERPRISE CORPORATION
Free supplier Enterprise Certification
- Free
supplier - 9th
years
Free supplier Enterprise Certification
Product Certification&
Enterprise Certification
Country: 
China (Mainland)
Business Type:Trading Company
Tel: +86-371- 86259723
Tel: 17734809689
Tel: 17734809689
Tel: 86-371-86259723
Tel: 17734809689
Tel: 17734809689
Mobile: 17734809689
Tel: +86-371- 86259723
Fax: +86-371- 86259723
Province/state: HENAN
City: ZHENGZHOU
Street: Mingmen International Center, NO.222 Dongming Road,Zhengzhou,Henan,China
MaxCard:
Contact Suppliers
CAS NO.171596-29-5
|
Preview |
|
| Cialis Basic information |
| Product Name: | Cialis |
| Synonyms: | TADALAFIL;CIALIS;IC 351;(6r,12ar)-6-(1,3-benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methyl-pyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione;TADALAFIL(CIALIS);Taladafil (cialis);Cialis/taladafil;Cialis(IC351) |
| CAS: | 171596-29-5 |
| MF: | C22H19N3O4 |
| MW: | 389.4 |
| EINECS: | 200-835-2 |
| Product Categories: | Active Pharmaceutical Ingredients;Cnbio;Erectile Dysfunction;Inhibitors;Intermediates & Fine Chemicals;Pharmaceuticals;API's;Steroid and Hormone;Inhibitor;API;Tadalafil;NUCYNTA |
| Mol File: | 171596-29-5.mol |
|
|
|
| Cialis Chemical Properties |
| mp | 298-300°C |
| storage temp. | Hygroscopic, -20 C Freezer, Under Inert Atmosphere |
| CAS DataBase Reference | 171596-29-5(CAS DataBase Reference) |
| Safety Information |
| Hazard Codes | F,Xn |
| Risk Statements | 11-20/21/22-36 |
| Safety Statements | 16-36/37 |
| Hazardous Substances Data | 171596-29-5(Hazardous Substances Data) |
| Cialis Usage And Synthesis |
| Drug for treatment of male erectile dysfunction disease |
Cialis is tadalafil, is an orally administrated drug developed by the pharmaceutical company Eli Lily for treatment of male erectile dysfunction disease. It belongs to the second generation of phosphodiesterase type 5 inhibitors. Study has shown that compared with sildenafil, the onset rate of Cialis is very rapid with about 15 ~ 20 min for onset and with long-term effects up to 36h. Its T1/2 was 17.5h. In a study including 348 cases of patients with mild to severe erectile dysfunction, male patients were randomized for being subject to 20 mg of tadalafil or placebo. The results have showed that, compared with placebo, the intercourse success rate at 24 and 36 hours after taking the drug are both improved with most male patients can successfully have sexual intercourse for twice within 36 hours. There is also no difference in the incidence and severity of the adverse drug reactions compared with placebo. In the tadalafil group, more than 5% of men get headache and indigestion. [Adverse reactions] it has no serious adverse reactions. No adverse reactions such as facial flushing, vision abnormalities after serving have been observed. There has been occasionally headache and indigestion. [Note] for patients serving nitrates, angina, heart disease, uncontrolled hypertension or hypotension. Patients who had got stroke within the past six months should be disabled. The above information is edited by the chemicalbook of Dai Xiongfeng. |
| Application | It is a kind of PDE-5 inhibitors which can be used for the treatment of male erectile dysfunction. It is also the second generation of phosphodiesterase type 5 inhibitors used to treat male erectile dysfunction |
| Chemical Properties | White to Off-White Cyrstalline Solid |
| Usage | Used for the treatment of erectile dysfunction. A phosphodiesterase 5 inhibitor |
| Usage | analgesic, norepinephrine uptake blocker, mu-opiod receptor agonist |
| Cialis Preparation Products And Raw materials |